Amplify Alternative Harve... (MJ)
Amplify Alternative Harvest ETF (MJ) Stock Price, Analysis & Data
No hay datos disponibles
| Precio de compra | 25.84 |
| Capitalización de mercado | n/a |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | n/a |
| Beta | n/a |
| EPS (TTM) | n/a |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | n/a |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | 26.19 |
| Volumen | 31,460 |
| Volumen medio (20D) | 38,553 |
| Abierto | 25.12 |
| Anterior Cerrar | 25.00 |
| Rango del día | 25.50 - 26.44 |
| Rango de 52 semanas | 21.05 - 46.75 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de MJ
The fund will normally invest at least 80% of its net assets in the securities that comprise the index. The index seeks to provide exposure to global and U.S. companies that (i) engage in the cultivation, production, marketing or distribution of cannabis, including industrial hemp; and/or (ii) engage in the production, marketing, transportation or distribution of products containing cannabis, including industrial hemp, for medical or non-medical ...
Desempeño financiero
En undefined, los ingresos de Amplify Alternative Harvest ETF fueron n/a, un aumento de undefined% en comparación con n/a del año anterior. Las ganancias fueron n/a, un aumento de undefined%.
Estados financieros
8 meses hace · Yahoo Finance Video
Tilray CEO says THC drink regulation will benefit cannabis companiesPresident Trump is expected to sign an executive order that could reclassify marijuana from a Schedule I to a Schedule III drug, which would enable cannabis to be federally classified for medical use....
